WO2022022065A1 - Method for establishing fingerprint spectrum of cervicodynia treatment granules, and application thereof - Google Patents

Method for establishing fingerprint spectrum of cervicodynia treatment granules, and application thereof Download PDF

Info

Publication number
WO2022022065A1
WO2022022065A1 PCT/CN2021/098703 CN2021098703W WO2022022065A1 WO 2022022065 A1 WO2022022065 A1 WO 2022022065A1 CN 2021098703 W CN2021098703 W CN 2021098703W WO 2022022065 A1 WO2022022065 A1 WO 2022022065A1
Authority
WO
WIPO (PCT)
Prior art keywords
granules
fingerprint
solution
ningtong
cervicodynia
Prior art date
Application number
PCT/CN2021/098703
Other languages
French (fr)
Chinese (zh)
Inventor
谭倩
刘杰
江玉娟
潘瑞雪
高超
许敏
王莉
Original Assignee
山东明仁福瑞达制药股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 山东明仁福瑞达制药股份有限公司 filed Critical 山东明仁福瑞达制药股份有限公司
Publication of WO2022022065A1 publication Critical patent/WO2022022065A1/en

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/86Signal analysis
    • G01N30/8675Evaluation, i.e. decoding of the signal into analytical information
    • G01N30/8686Fingerprinting, e.g. without prior knowledge of the sample components

Definitions

  • the invention belongs to the technical field of medical detection, and in particular relates to a method for establishing a fingerprint of neck pain granules and its application.
  • Ningtong Granules are made according to the prescription of Professor Sun Shuchun. It is the first national-level new drug for the professional treatment of radiculopathy of cervical spondylosis, an independent innovation product of Shandong province, and a national key new product.
  • the medicine is made from seven herbs of Panax notoginseng, Chuanxiong, Corydalis, Qianghuo, Baishao, Weilingxian and Pueraria, of which Panax notoginseng, Chuanxiong and Corydalis play the role of promoting blood circulation, dispersing blood stasis and dredging collaterals; Qianghuo, Weilingxian , Puerariae has the effect of dispelling wind, cold and dampness, and relieving neck stiffness; while Baishao focuses on nourishing blood and softening yin, nourishing tendons and meridians, and its main functions are "activating blood and removing blood stasis, promoting qi and relieving pain". It is used for cervical spondylosis of nerve root type, which belongs to the syndrome of blood stasis and qi stagnation and choroid blocking.
  • the present invention provides a method for establishing a fingerprint of neck pain granules and a fingerprint thereof.
  • the present invention relates to the following technical solutions:
  • a method for establishing a fingerprint of Necktong Granules uses Panax notoginseng saponin R1, tetrahydropalmatine and oleanolic acid as mixed standards.
  • the steps are as follows:
  • test solution take the neck pain granules, add methanol for ultrasonic extraction, and filter to obtain the solution to be tested;
  • reference substance solution preparation get notoginseng saponin R1, tetrahydropalmatine and oleanolic acid reference substance dried under reduced pressure to constant weight and add methanol to make mixed reference substance solution;
  • the second aspect of the present invention provides the fingerprint of the neck pain granules obtained by the establishment method.
  • the third aspect of the present invention provides the application of the establishment method and/or fingerprint in the quality control of Jingtong Granules.
  • a fourth aspect of the present invention provides a quality control method for Ningtong Granules, the method comprising: taking multiple batches of Ningtong Granules to obtain the fingerprints of Ningtong Granules according to the construction method, and obtaining the fingerprints of Ningtong Granules from the multiple batches ( Generally at least 10 batches) the fingerprints of Ningtong Granules are generated according to the mean value method to obtain the control fingerprints;
  • the technical scheme adopts the gradient elution method to establish the fingerprint of the neck pain granules.
  • the method is simple to operate, stable and reliable, has high precision, good separation, and the stability and reproducibility of the fingerprint are good, and the amount of information is high. Large, can fully reflect the information of the overall chemical composition of Jingtong Granules;
  • the technical solution not only avoids the one-sidedness of judging the overall quality of the preparation due to the determination of only a single chemical component, but also reduces the possibility of artificial processing to meet the quality standards.
  • Comprehensive and scientific evaluation of the quality of Ningtong Granules so as to ensure the quality and efficacy of the products, and provide a good solution for the quality control of Ningtong Granules, so it is of great practical application value.
  • Fig. 1 is the HPLC figure of mixed reference substance in the embodiment of the present invention.
  • Fig. 2 is the HPLC fingerprints of 14 batches of Neck Pain Granules in the embodiment of the present invention.
  • a method for establishing a fingerprint of Ningtong Granules uses notoginsenoside R1, tetrahydropalmatine and oleanolic acid as mixed standards.
  • the method for establishing a fingerprint spectrum includes the following steps:
  • test solution take the neck pain granules, add methanol for ultrasonic extraction, and filter to obtain the solution to be tested;
  • a certain amount of Neck Pain Granules is weighed and added to methanol and then ultrasonicated for 10-30 min (preferably 20 min), wherein the ratio of Neck Pain Granules: methanol is (80- 120) mg: (4-6) mL (preferably 100 mg: 5 mL); after ultrasonic extraction, shake well and filter, and the filtrate is filtered through a 0.22 ⁇ m microporous membrane to obtain the test solution;
  • the preparation method of the mixed reference solution in the step (2) is as follows: Precisely weigh 0.0100 g of notoginsenoside R1 standard product, 0.0099 g of tetrahydropalmatine standard product and oleanolic acid Place 0.0099g of the standard in a 10mL volumetric flask, add methanol to dissolve and dilute to the mark, and prepare a mixed standard solution.
  • the chromatographic column is CAPCELL PAK C18 MGII (4.6mm ⁇ 250mm, 5 ⁇ m); the flow rate of the mobile phase is 1ml/min; the column temperature is 30°C; the detection wavelength is 300nm, the injection volume is 10 ⁇ L.
  • the gradient elution mode in step (3) is: gradient elution: 0-15min, 2%A ⁇ 15%A; 15-30min, 15%A ⁇ 30%A; 30 ⁇ 45min, 30%A ⁇ 50%A; 45 ⁇ 60min, 50%A ⁇ 65%A; 60 ⁇ 75min, 65%A ⁇ 100%A.
  • the chromatogram of 2h was recorded when the elution time of the fingerprint was selected. The results showed that there were basically no obvious chromatographic peaks after 65min.
  • 75min was selected as the analysis time.
  • the gradient elution conditions were optimized, the retention time of each chromatographic peak was moderate, the resolution of the chromatogram was improved, the tailing phenomenon of the chromatogram was avoided, and the detection and analysis of the chromatographic fingerprint was facilitated.
  • the fingerprint of the neck pain granules obtained by the establishment method is provided.
  • the application of the establishment method and/or the fingerprint in the quality control of Jingtong Granules is provided.
  • a method for quality control of Ningtong Granules comprising: taking multiple batches of Ningtong Granules to obtain the fingerprint of Ningtong Granules according to the construction method, and obtaining the fingerprints of Ningtong Granules from the multiple batches
  • the fingerprints of Ningtong Granules are generated every time (generally at least 10 batches) according to the mean value method to obtain the control fingerprints;
  • Japan Shiseido CAPCELL PAK C18 MGII (4.6mm ⁇ 250mm, 5 ⁇ m); mobile phase: acetonitrile (A)-0.15% phosphoric acid aqueous solution (B). Gradient elution: 0 ⁇ 15min, 2%A ⁇ 15%A; 15 ⁇ 30min, 15%A ⁇ 30%A; 30 ⁇ 45min, 30%A ⁇ 50%A; 45 ⁇ 60min, 50%A ⁇ 65% A; 60 ⁇ 75min, 65%A ⁇ 100%A.
  • the flow rate of the mobile phase was 1 ml/min; the column temperature was 30 °C; the detection wavelength was 300 nm, and the injection volume was 10 ⁇ L.
  • the obtained spectrum was analyzed and processed with fingerprint spectrum software to obtain the fingerprint spectrum of each batch of Ningtong Granules (as shown in Figure 2). There are 22 common characteristic peaks in the spectrum.
  • the fingerprint of the mixed reference substance is shown in Figure 1. By comparing with the chromatogram of the reference substance, it is confirmed that the No. 4 peak is oleanolic acid, the No. 6 peak is notoginsenoside R1, and the No. 21 peak is tetrahydropalmatine.
  • the methodological investigation mainly examines the precision, stability and repeatability.
  • the investigation methods and results are as follows: (1) The same batch of Ningtong Granules samples were taken in the precision experiment. , and the results are shown in Table 2. It can be seen from Table 2 that the relative retention time of each common peak and the RSD of the relative peak are both less than 3%, indicating that the precision of the instrument is good.

Landscapes

  • Engineering & Computer Science (AREA)
  • Library & Information Science (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method for establishing a fingerprint spectrum of cervicodynia treatment granules, and the use thereof, which belong to the technical field of medicine testing. On the basis of HPLC technology, a gradient elution method is used to establish a fingerprint spectrum of cervicodynia treatment granules. The method is simple in terms of operation, stable, reliable, and high in precision, and achieves a good degree of separation. The fingerprint spectrum is better in terms of stability and reproducibility and large in terms of information amount, and can fully reflect information of whole chemical components of the cervicodynia treatment granules. By means of the method, one-sidedness in the determination of the overall quality of a preparation due to the fact that only a single chemical component is measured is avoided, and the possibility of manual treatment being required for reaching a quality standard is also reduced; in addition, systematic analysis is performed on a plurality of batches of samples, so that the quality of cervicodynia treatment granules can be evaluated more comprehensively and scientifically, thereby ensuring the quality and the curative effect of a product, and providing a good solution for quality control over cervicodynia treatment granules.

Description

一种颈痛颗粒指纹图谱的建立方法及其应用A kind of establishment method of neck pain granule fingerprint and its application 技术领域technical field
本发明属于医药检测技术领域,具体涉及一种颈痛颗粒指纹图谱的建立方法及其应用。The invention belongs to the technical field of medical detection, and in particular relates to a method for establishing a fingerprint of neck pain granules and its application.
背景技术Background technique
公开该背景技术部分的信息仅仅旨在增加对本发明的总体背景的理解,而不必然被视为承认或以任何形式暗示该信息构成已经成为本领域一般技术人员所公知的现有技术。The information disclosed in this Background section is only for enhancement of understanding of the general background of the invention and should not necessarily be taken as an acknowledgement or any form of suggestion that this information forms the prior art already known to a person of ordinary skill in the art.
颈痛颗粒根据孙树椿教授的组方制成,是国内首个专业治疗神经根型颈椎病的国家级新药、山东省自主创新产品、国家重点新产品。该药由三七、川芎、延胡索、羌活、白芍、威灵仙、葛根七味药制成,其中三七、川芎、延胡索起到活血行气、散瘀通络的作用;羌活、威灵仙、葛根有祛风寒湿邪外出、缓解颈项强紧的功效;而白芍则着力于养血柔阴、濡养筋脉,主要功效是“活血化瘀、行气止痛”。用于神经根型颈椎病属血瘀气滞、脉络闭阻证。Ningtong Granules are made according to the prescription of Professor Sun Shuchun. It is the first national-level new drug for the professional treatment of radiculopathy of cervical spondylosis, an independent innovation product of Shandong Province, and a national key new product. The medicine is made from seven herbs of Panax notoginseng, Chuanxiong, Corydalis, Qianghuo, Baishao, Weilingxian and Pueraria, of which Panax notoginseng, Chuanxiong and Corydalis play the role of promoting blood circulation, dispersing blood stasis and dredging collaterals; Qianghuo, Weilingxian , Puerariae has the effect of dispelling wind, cold and dampness, and relieving neck stiffness; while Baishao focuses on nourishing blood and softening yin, nourishing tendons and meridians, and its main functions are "activating blood and removing blood stasis, promoting qi and relieving pain". It is used for cervical spondylosis of nerve root type, which belongs to the syndrome of blood stasis and qi stagnation and choroid blocking.
目前,2015年版《中华人民共和国药典》(一部)仅采用薄层色谱法结合对照品延胡索乙素、紫花前胡苷、芍药苷等和对照药材川芎对颈痛颗粒进行鉴别,或采用高效液相色谱法测定人参皂苷Rg 1、人参皂苷Rb 1和三七皂苷R 1的含量,质控指标单一,不能全面反映中药方剂多成分、多靶点的特点。而如前所述,中药及其复方是在中医理论指导下进行应用研究的,其成分复杂,发挥药效的部位往往不是单一成分,而是群体疗效,所以任何一种单一成分都是无法反应中药及其复方的整体疗效的。因此,对中药及其复方进行宏观地综合分析将成为必然的趋势。 At present, the 2015 edition of the Pharmacopoeia of the People's Republic of China (Part I) only uses thin-layer chromatography combined with reference substances such as tetrahydropalmatate, tetrahydropalmatine, paeoniflorin, etc. and reference medicinal material Chuanxiong to identify Jingtong granules, or use high-efficiency liquid The content of ginsenoside Rg 1 , ginsenoside Rb 1 and Panax notoginseng saponin R 1 was determined by liquid chromatography, and the quality control index was single, which could not fully reflect the multi-component and multi-target characteristics of traditional Chinese medicine prescriptions. As mentioned above, traditional Chinese medicine and its compound prescriptions are applied and researched under the guidance of traditional Chinese medicine theory. Their components are complex, and the parts that exert their effects are often not a single component, but a group effect, so any single component cannot respond. The overall efficacy of traditional Chinese medicine and its compounds. Therefore, it will become an inevitable trend to carry out a macroscopic comprehensive analysis of traditional Chinese medicine and its compound prescriptions.
中药指纹图谱依托各种光谱、波谱、色谱技术综合地反应中药及其复方的质量信息,目前已成为国际公认的中药及其复方质量控制的重要手段。但发明 人发现,目前针对颈痛颗粒基于指纹图谱的质量控制研究尚未见报道,因此提供一种颈痛颗粒的指纹图谱建立方法具有重要意义。Traditional Chinese medicine fingerprints rely on various spectral, spectral and chromatographic techniques to comprehensively reflect the quality information of traditional Chinese medicines and their compounds. However, the inventor found that there is no report on the quality control research based on fingerprints for Ningtong Granules at present, so it is of great significance to provide a method for establishing fingerprints of Ningtong Granules.
发明内容SUMMARY OF THE INVENTION
针对现有技术的不足,本发明提供一种颈痛颗粒指纹图谱的建立方法及其指纹图谱。针对颈痛颗粒作为一种中药复方制剂,由7味处方药材组成、成分复杂多样、且尚未完全明确等特点,通过研究试验,进一步对颈痛颗粒中特征性成分有效分离,使其形成特征峰多且能够有效表征颈痛颗粒制剂质量的指纹图谱,从而完成本发明。In view of the deficiencies of the prior art, the present invention provides a method for establishing a fingerprint of neck pain granules and a fingerprint thereof. Aiming at the characteristics of Jingtong Granules as a traditional Chinese medicine compound preparation, it is composed of 7 prescription medicinal materials, and the components are complex and diverse, and have not yet been fully clarified. There are many fingerprints that can effectively characterize the quality of the Jingtong granule preparation, thereby completing the present invention.
为了实现所述目的,本发明涉及以下技术方案:In order to achieve the purpose, the present invention relates to the following technical solutions:
本发明的第一个方面,提供一种颈痛颗粒的指纹图谱建立方法,该方法以三七皂苷R1、延胡索乙素及齐墩果酸为混合标准品。In a first aspect of the present invention, a method for establishing a fingerprint of Necktong Granules is provided. The method uses Panax notoginseng saponin R1, tetrahydropalmatine and oleanolic acid as mixed standards.
优选的,所述指纹图谱建立方法,其步骤如下:Preferably, the method for establishing the fingerprint spectrum, the steps are as follows:
(1)供试品溶液的制备:取颈痛颗粒,加入甲醇超声提取,过滤后即得待测液;(1) Preparation of the test solution: take the neck pain granules, add methanol for ultrasonic extraction, and filter to obtain the solution to be tested;
(2)对照品溶液制备:取减压干燥至恒重的三七皂苷R1、延胡索乙素及齐墩果酸对照品加入甲醇制成混合对照品溶液;(2) reference substance solution preparation: get notoginseng saponin R1, tetrahydropalmatine and oleanolic acid reference substance dried under reduced pressure to constant weight and add methanol to make mixed reference substance solution;
(3)测定:分别精密量取供试品溶液和对照品溶液,进行HPLC分析,采用梯度洗脱,流动相A相:乙腈,流动相B相:0.15%磷酸水溶液;对高效液相色谱测定所得图谱进行分析处理,即得颈痛颗粒指纹图谱。(3) Determination: Precisely measure the test solution and the reference solution respectively, carry out HPLC analysis, adopt gradient elution, mobile phase A phase: acetonitrile, mobile phase B phase: 0.15% phosphoric acid aqueous solution; The obtained spectrum is analyzed and processed to obtain the fingerprint spectrum of Ningtong Granules.
可以理解的是,所述步骤(1)和(2)之间并不存在先后顺序之分。It can be understood that, there is no sequence between the steps (1) and (2).
本发明的第二个方面,提供所述建立方法获得的颈痛颗粒的指纹图谱。The second aspect of the present invention provides the fingerprint of the neck pain granules obtained by the establishment method.
本发明的第三个方面,提供所述建立方法和/或指纹图谱在颈痛颗粒质量控制中的应用。The third aspect of the present invention provides the application of the establishment method and/or fingerprint in the quality control of Jingtong Granules.
本发明的第四个方面,提供一种颈痛颗粒的质量控制方法,所述方法包括:取多批次颈痛颗粒按照所述构建方法得到颈痛颗粒指纹图谱,将该多个批次(一般至少10个批次)颈痛颗粒指纹图谱按照均值法生成得到对照指纹图谱;A fourth aspect of the present invention provides a quality control method for Ningtong Granules, the method comprising: taking multiple batches of Ningtong Granules to obtain the fingerprints of Ningtong Granules according to the construction method, and obtaining the fingerprints of Ningtong Granules from the multiple batches ( Generally at least 10 batches) the fingerprints of Ningtong Granules are generated according to the mean value method to obtain the control fingerprints;
取待检测样品制备供试品溶液,按照所述构建方法得到颈痛颗粒指纹图谱;Take the sample to be detected to prepare the test solution, and obtain the fingerprint of Neck Pain Granules according to the construction method;
将待检测样品指纹图谱与颈痛颗粒对照指纹图谱进行相似性比较。The similarity between the fingerprints of the samples to be tested and the control fingerprints of Jingtong Granules was compared.
优选的,所述相似性比较包括采用夹角余弦法和/或相关系数法进行。Preferably, the similarity comparison includes using an included angle cosine method and/or a correlation coefficient method.
所述一个或多个技术方案的有益技术效果:Beneficial technical effects of the one or more technical solutions:
所述技术方案采用梯度洗脱的方法建立了颈痛颗粒的指纹图谱,该方法操作简单,稳定可靠,精密度高,分离度好,指纹图谱的稳定性和重现性较好,且信息量大,能够充分反映颈痛颗粒整体化学成分的信息;The technical scheme adopts the gradient elution method to establish the fingerprint of the neck pain granules. The method is simple to operate, stable and reliable, has high precision, good separation, and the stability and reproducibility of the fingerprint are good, and the amount of information is high. Large, can fully reflect the information of the overall chemical composition of Jingtong Granules;
所述技术方案既避免了因只测定单一化学成分而判定制剂整体质量的片面性,又减少了为质量达标而人为处理的可能性,同时通过对多个批次的样品进行系统分析,从而能够更加全面、科学评价颈痛颗粒的质量,从而保证产品的质量和疗效,为颈痛颗粒的质量控制提供了良好的解决方案,因此极具实际应用之价值。The technical solution not only avoids the one-sidedness of judging the overall quality of the preparation due to the determination of only a single chemical component, but also reduces the possibility of artificial processing to meet the quality standards. Comprehensive and scientific evaluation of the quality of Ningtong Granules, so as to ensure the quality and efficacy of the products, and provide a good solution for the quality control of Ningtong Granules, so it is of great practical application value.
附图说明Description of drawings
构成本发明的一部分的说明书附图用来提供对本发明的进一步理解,本发明的示意性实施例及其说明用于解释本发明,并不构成对本发明的不当限定。The accompanying drawings forming a part of the present invention are used to provide further understanding of the present invention, and the exemplary embodiments of the present invention and their descriptions are used to explain the present invention, and do not constitute an improper limitation of the present invention.
图1为本发明实施例中混合对照品的HPLC图;Fig. 1 is the HPLC figure of mixed reference substance in the embodiment of the present invention;
图2为本发明实施例中14批次颈痛颗粒的HPLC指纹图谱。Fig. 2 is the HPLC fingerprints of 14 batches of Neck Pain Granules in the embodiment of the present invention.
具体实施方式detailed description
应该指出,以下详细说明都是例示性的,旨在对本发明提供进一步的说明。除非另有指明,本文使用的所有技术和科学术语具有与本发明所属技术领域的普通技术人员通常理解的相同含义。It should be noted that the following detailed description is exemplary and intended to provide further explanation of the invention. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
需要注意的是,这里所使用的术语仅是为了描述具体实施方式,而非意图限制根据本发明的示例性实施方式。如在这里所使用的,除非上下文另外明确指出,否则单数形式也意图包括复数形式,此外,还应当理解的是,当在本说明书中使用术语“包含”和/或“包括”时,其指明存在特征、步骤、操作、器件、 组件和/或它们的组合。应理解,本发明的保护范围不局限于下述特定的具体实施方案;还应当理解,本发明实施例中使用的术语是为了描述特定的具体实施方案,而不是为了限制本发明的保护范围。It should be noted that the terminology used herein is for the purpose of describing specific embodiments only, and is not intended to limit the exemplary embodiments according to the present invention. As used herein, unless the context clearly dictates otherwise, the singular is intended to include the plural as well, furthermore, it is to be understood that when the terms "comprising" and/or "including" are used in this specification, it indicates that There are features, steps, operations, devices, components, and/or combinations thereof. It should be understood that the protection scope of the present invention is not limited to the following specific specific embodiments; it should also be understood that the terms used in the examples of the present invention are for describing specific specific embodiments, rather than for limiting the protection scope of the present invention.
本发明的一个具体实施方式中,提供一种颈痛颗粒的指纹图谱建立方法,该方法以三七皂苷R1、延胡索乙素及齐墩果酸为混合标准品。In a specific embodiment of the present invention, a method for establishing a fingerprint of Ningtong Granules is provided, and the method uses notoginsenoside R1, tetrahydropalmatine and oleanolic acid as mixed standards.
本发明的又一具体实施方式中,所述指纹图谱建立方法,其步骤如下:In yet another specific embodiment of the present invention, the method for establishing a fingerprint spectrum includes the following steps:
(1)供试品溶液的制备:取颈痛颗粒,加入甲醇超声提取,过滤后即得待测液;(1) Preparation of the test solution: take the neck pain granules, add methanol for ultrasonic extraction, and filter to obtain the solution to be tested;
(2)对照品溶液制备:取减压干燥至恒重的三七皂苷R1、延胡索乙素及齐墩果酸对照品加入甲醇制成混合对照品溶液;(2) reference substance solution preparation: get notoginseng saponin R1, tetrahydropalmatine and oleanolic acid reference substance dried under reduced pressure to constant weight and add methanol to make mixed reference substance solution;
(3)测定:分别精密量取供试品溶液和对照品溶液,进行HPLC分析,采用梯度洗脱,流动相A相:乙腈,流动相B相:0.15%磷酸水溶液;对高效液相色谱测定所得图谱进行分析处理,即得颈痛颗粒指纹图谱。(3) Determination: Precisely measure the test solution and the reference solution respectively, carry out HPLC analysis, adopt gradient elution, mobile phase A phase: acetonitrile, mobile phase B phase: 0.15% phosphoric acid aqueous solution; The obtained spectrum is analyzed and processed to obtain the fingerprint spectrum of Ningtong Granules.
可以理解的是,所述步骤(1)和(2)之间并不存在先后顺序之分。It can be understood that, there is no sequence between the steps (1) and (2).
本发明的又一具体实施方式中,所述步骤(1)中称取一定量的颈痛颗粒加入甲醇后超声10-30min(优选为20min),其中颈痛颗粒:甲醇的比为(80-120)mg:(4-6)mL(优选为100mg:5mL);超声提取后摇匀过滤,滤液过0.22μm微孔滤膜后得供试品溶液;In another specific embodiment of the present invention, in the step (1), a certain amount of Neck Pain Granules is weighed and added to methanol and then ultrasonicated for 10-30 min (preferably 20 min), wherein the ratio of Neck Pain Granules: methanol is (80- 120) mg: (4-6) mL (preferably 100 mg: 5 mL); after ultrasonic extraction, shake well and filter, and the filtrate is filtered through a 0.22 μm microporous membrane to obtain the test solution;
本发明的又一具体实施方式中,所述步骤(2)中混合对照品溶液的配制方法如下:精密称取三七皂苷R1标准品0.0100g、延胡索乙素标准品0.0099g和齐墩果酸标准品0.0099g置10mL容量瓶中,加甲醇溶解并稀释至刻度,配置混合标准品溶液。In yet another specific embodiment of the present invention, the preparation method of the mixed reference solution in the step (2) is as follows: Precisely weigh 0.0100 g of notoginsenoside R1 standard product, 0.0099 g of tetrahydropalmatine standard product and oleanolic acid Place 0.0099g of the standard in a 10mL volumetric flask, add methanol to dissolve and dilute to the mark, and prepare a mixed standard solution.
本发明的又一具体实施方式中,所述步骤(3)中色谱柱为CAPCELL PAK C18 MGII(4.6mm×250mm,5μm);流动相流速为1ml/min;柱温为30℃;检测波长为300nm,进样量10μL。In another specific embodiment of the present invention, in the step (3), the chromatographic column is CAPCELL PAK C18 MGII (4.6mm×250mm, 5μm); the flow rate of the mobile phase is 1ml/min; the column temperature is 30°C; the detection wavelength is 300nm, the injection volume is 10μL.
本发明的又一具体实施方式中,步骤(3)中梯度洗脱方式为:梯度洗脱: 0~15min,2%A→15%A;15~30min,15%A→30%A;30~45min,30%A→50%A;45~60min,50%A→65%A;60~75min,65%A→100%A。需要说明的是,在选择指纹图谱的洗脱时间时记录了2h的色谱图。结果表明65min以后基本没有明显的色谱峰出现,同时为了照顾各批次样品的差异性,保证所有批次样品的特征峰都能够被检出,因此选择75min作为分析时间。并对梯度洗脱条件进行优化,各色谱峰保留时间适中,提高了色谱图的分离度,避免色谱图的拖尾现象,从而有利于色谱指纹图谱的检测和分析。In another specific embodiment of the present invention, the gradient elution mode in step (3) is: gradient elution: 0-15min, 2%A→15%A; 15-30min, 15%A→30%A; 30 ~45min, 30%A→50%A; 45~60min, 50%A→65%A; 60~75min, 65%A→100%A. It should be noted that the chromatogram of 2h was recorded when the elution time of the fingerprint was selected. The results showed that there were basically no obvious chromatographic peaks after 65min. At the same time, in order to take into account the differences of each batch of samples and ensure that the characteristic peaks of all batches of samples could be detected, 75min was selected as the analysis time. The gradient elution conditions were optimized, the retention time of each chromatographic peak was moderate, the resolution of the chromatogram was improved, the tailing phenomenon of the chromatogram was avoided, and the detection and analysis of the chromatographic fingerprint was facilitated.
本发明的又一具体实施方式中,如前所述颈痛颗粒指纹图谱构建方法得到的颈痛颗粒指纹图谱,该指纹图谱中的共有峰为22个。In yet another specific embodiment of the present invention, in the fingerprint of Ningtong Granules obtained by the method for constructing the fingerprint of Ningtong Granules as described above, there are 22 common peaks in the fingerprint.
本发明的又一具体实施方式中,提供所述建立方法获得的颈痛颗粒的指纹图谱。In another specific embodiment of the present invention, the fingerprint of the neck pain granules obtained by the establishment method is provided.
本发明的又一具体实施方式中,提供所述建立方法和/或指纹图谱在颈痛颗粒质量控制中的应用。In yet another specific embodiment of the present invention, the application of the establishment method and/or the fingerprint in the quality control of Jingtong Granules is provided.
本发明的又一具体实施方式中,提供一种颈痛颗粒的质量控制方法,所述方法包括:取多批次颈痛颗粒按照所述构建方法得到颈痛颗粒指纹图谱,将该多个批次(一般至少10个批次)颈痛颗粒指纹图谱按照均值法生成得到对照指纹图谱;In another specific embodiment of the present invention, a method for quality control of Ningtong Granules is provided, the method comprising: taking multiple batches of Ningtong Granules to obtain the fingerprint of Ningtong Granules according to the construction method, and obtaining the fingerprints of Ningtong Granules from the multiple batches The fingerprints of Ningtong Granules are generated every time (generally at least 10 batches) according to the mean value method to obtain the control fingerprints;
取待检测样品制备供试品溶液,按照所述构建方法得到颈痛颗粒指纹图谱。Take the sample to be tested to prepare the test solution, and obtain the fingerprint of Ningtong Granules according to the construction method.
将待检测样品指纹图谱与颈痛颗粒对照指纹图谱进行相似性比较。The similarity between the fingerprints of the samples to be tested and the control fingerprints of Jingtong Granules was compared.
以下通过实施例对本发明做进一步解释说明,但不构成对本发明的限制。应理解这些实施例仅用于说明本发明而不用于限制本发明的范围。The present invention is further explained and illustrated by the following examples, but it does not constitute a limitation of the present invention. It should be understood that these examples are only intended to illustrate the present invention and not to limit the scope of the present invention.
实施例1Example 1
1、仪器与材料1. Instruments and materials
安捷伦(agilent1200)高效液相色谱仪;赛多利斯十万分之一电子分析天平、指纹图谱相似度评价软件为“中药色谱指纹相似度评价系统”(国家药典委员会2004A版);KQ-1000DE型数控超声波仪。Agilent (agilent1200) high performance liquid chromatograph; Sartorius 1/100,000 electronic analytical balance, fingerprint similarity evaluation software "Chinese medicine chromatographic fingerprint similarity evaluation system" (National Pharmacopoeia Commission 2004A version); KQ-1000DE type CNC Ultrasound.
色谱柱:日本资生堂CAPCELL PAK C18 MGII(4.6mm×250mm,5μm),三七皂苷R1、延胡索乙素和齐墩果酸标准品均购于上海纯优生物科技有限公司。Chromatographic column: Japan Shiseido CAPCELL PAK C18 MGII (4.6mm×250mm, 5μm), notoginseng saponin R1, tetrahydropalmatine and oleanolic acid standard products were purchased from Shanghai Chunyou Biotechnology Co., Ltd.
磷酸、甲醇(色谱纯,山东创益化工有限公司);乙腈(色谱纯,美国费希尔Fisher);实验用水为超纯水(18MΩ);14批次(S1-S14)颈痛颗粒(明仁)样品取自山东明仁福瑞达制药股份有限公司。Phosphoric acid, methanol (chromatographically pure, Shandong Chuangyi Chemical Co., Ltd.); acetonitrile (chromatographically pure, Fisher, USA); experimental water was ultrapure water (18MΩ); 14 batches (S1-S14) of neck pain granules (Mingren ) samples were taken from Shandong Mingren Freda Pharmaceutical Co., Ltd.
2、实验方法2. Experimental method
2.1供试品溶液的制备2.1 Preparation of the test solution
取颈痛颗粒0.5g,精密称定,置于具塞锥形瓶中,加入10mL色谱甲醇,超声提取20min(提取功率300W,频率40kHz),摇匀,过滤,滤液过0.22μm微孔滤膜后作为供试品溶液,备用。Take 0.5 g of Neck Pain Granules, accurately weigh them, put them in a stoppered conical flask, add 10 mL of chromatographic methanol, extract by ultrasonic for 20 min (extraction power 300 W, frequency 40 kHz), shake well, filter, and filter the filtrate through a 0.22 μm microporous membrane Afterwards, it was used as the test solution for use.
2.2混合对照品溶液的制备2.2 Preparation of mixed reference solution
精密称取三七皂苷R1标准品0.0100g、延胡索乙素标准品0.0099g和齐墩果酸标准品0.0099g置10mL容量瓶中,加色谱甲醇溶解并稀释至刻度,配置混合标准品溶液。Precisely weigh 0.0100 g of notoginsenoside R1 standard product, 0.0099 g of tetrahydropalmatine standard product and 0.0099 g of oleanolic acid standard product into a 10 mL volumetric flask, add chromatographic methanol to dissolve and dilute to the mark, and prepare a mixed standard solution.
2.3色谱条件2.3 Chromatographic conditions
日本资生堂CAPCELL PAK C18 MGII(4.6mm×250mm,5μm);流动相:乙腈(A)-0.15%磷酸水溶液(B)。梯度洗脱:0~15min,2%A→15%A;15~30min,15%A→30%A;30~45min,30%A→50%A;45~60min,50%A→65%A;60~75min,65%A→100%A。流动相流速为1ml/min;柱温为30℃;检测波长为300nm,进样量10μL。Japan Shiseido CAPCELL PAK C18 MGII (4.6mm×250mm, 5μm); mobile phase: acetonitrile (A)-0.15% phosphoric acid aqueous solution (B). Gradient elution: 0~15min, 2%A→15%A; 15~30min, 15%A→30%A; 30~45min, 30%A→50%A; 45~60min, 50%A→65% A; 60~75min, 65%A→100%A. The flow rate of the mobile phase was 1 ml/min; the column temperature was 30 °C; the detection wavelength was 300 nm, and the injection volume was 10 μL.
3、结果与讨论3. Results and discussion
3.1指纹图谱的比较3.1 Comparison of fingerprints
用指纹图谱软件对所得图谱进行分析处理,即得各批次颈痛颗粒指纹图谱(如图2)。图谱共有22个共有特征峰。混合对照品的指纹图谱如图1所示, 通过与对照品色谱图比较,确认4号峰为齐墩果酸,6号峰为三七皂苷R1,21号峰为延胡索乙素。The obtained spectrum was analyzed and processed with fingerprint spectrum software to obtain the fingerprint spectrum of each batch of Ningtong Granules (as shown in Figure 2). There are 22 common characteristic peaks in the spectrum. The fingerprint of the mixed reference substance is shown in Figure 1. By comparing with the chromatogram of the reference substance, it is confirmed that the No. 4 peak is oleanolic acid, the No. 6 peak is notoginsenoside R1, and the No. 21 peak is tetrahydropalmatine.
将所测的14批次颈痛颗粒图谱导入“中药色谱指纹相似度评价系统”软件分析,进行色谱峰匹配。以S1作为参照图谱,生成的对照指纹图谱为R(采用平均法,见图1)。各批次样品的指纹图谱与对照指纹图谱以及各样品之间指纹图谱的相似度结果见表1。The measured spectra of 14 batches of Ningtong Granules were imported into the software of "Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System" for analysis, and chromatographic peak matching was performed. Taking S1 as the reference spectrum, the generated control fingerprint spectrum is R (using the average method, see Figure 1). The fingerprints of each batch of samples and the control fingerprints and the similarity results of the fingerprints between the samples are shown in Table 1.
表1 14个批次指纹图谱的相似度值Table 1 Similarity values of 14 batches of fingerprints
Figure PCTCN2021098703-appb-000001
Figure PCTCN2021098703-appb-000001
Figure PCTCN2021098703-appb-000002
Figure PCTCN2021098703-appb-000002
由表1中可以看出,各批次样品与R的相似度均在0.900以上,说明颈痛颗粒各批次样品的化学组成总体上较为相近。It can be seen from Table 1 that the similarity between each batch of samples and R is more than 0.900, indicating that the chemical composition of each batch of Jingtong Granules is generally similar.
3.2方法学考察3.2 Methodological investigation
方法学考察主要考察了精密度、稳定性和重复性,考察方法和结果如下:(1)精密度实验取同一批次颈痛颗粒样品,在上述色谱条件下,连续测定6 次,记录色谱图,结果见表2。由表2可知,各共有峰相对保留时间和相对峰的RSD均小于3%,说明仪器精密度良好。The methodological investigation mainly examines the precision, stability and repeatability. The investigation methods and results are as follows: (1) The same batch of Ningtong Granules samples were taken in the precision experiment. , and the results are shown in Table 2. It can be seen from Table 2 that the relative retention time of each common peak and the RSD of the relative peak are both less than 3%, indicating that the precision of the instrument is good.
(2)稳定性实验取同一批次颈痛颗粒样品,在上述色谱条件下,分别于0h,2h,4h,8h,12h和24h进样分析,记录色谱图,结果见表2。由表2可见,各共有峰相对保留时间和相对峰的RSD均小于3%,说明供试品溶液成分在24h内稳定。(2) Stability experiment Take the same batch of Jingtong granules samples, under the above chromatographic conditions, inject samples for analysis at 0h, 2h, 4h, 8h, 12h and 24h respectively, record the chromatogram, and the results are shown in Table 2. It can be seen from Table 2 that the relative retention time of each common peak and the RSD of the relative peak are both less than 3%, indicating that the components of the test solution are stable within 24 hours.
(3)重复性实验取同一批次的颈痛颗粒样品,在上述色谱条件下,分别进样分析,记录色谱图,结果见表2,各共有峰相对保留时间和相对峰的RSD均小于3%,说明该实验方法具有较佳的重复性。(3) Repeatability experiment Take the same batch of Neck Pain Granules samples, under the above chromatographic conditions, inject and analyze respectively, record the chromatogram, the results are shown in Table 2, the relative retention time of each common peak and the RSD of the relative peak are both less than 3 %, indicating that the experimental method has better repeatability.
表2 颈痛颗粒指纹图谱方法学验证结果Table 2 Methodological verification results of neck pain granules fingerprints
Figure PCTCN2021098703-appb-000003
Figure PCTCN2021098703-appb-000003
Figure PCTCN2021098703-appb-000004
Figure PCTCN2021098703-appb-000004
应注意的是,以上实例仅用于说明本发明的技术方案而非对其进行限制。尽管参照所给出的实例对本发明进行了详细说明,但是本领域的普通技术人员可根据需要对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的精神和范围。It should be noted that the above examples are only used to illustrate the technical solutions of the present invention but not to limit them. Although the present invention has been described in detail with reference to the given examples, those skilled in the art can modify or equivalently replace the technical solutions of the present invention as required without departing from the spirit and scope of the technical solutions of the present invention.

Claims (10)

  1. 一种颈痛颗粒的指纹图谱建立方法,其特征在于,所述方法以三七皂苷R1、延胡索乙素及齐墩果酸为混合标准品。A method for establishing a fingerprint of Ningtong Granules, characterized in that the method uses notoginsenoside R1, tetrahydropalmatine and oleanolic acid as mixed standards.
  2. 如权利要求1所述的方法,其特征在于,步骤如下:The method of claim 1, wherein the steps are as follows:
    (1)供试品溶液的制备:取颈痛颗粒,加入甲醇超声提取,过滤后即得待测液;(1) Preparation of the test solution: take the neck pain granules, add methanol for ultrasonic extraction, and filter to obtain the solution to be tested;
    (2)对照品溶液制备:取减压干燥至恒重的三七皂苷R1、延胡索乙素及齐墩果酸对照品加入甲醇制成混合对照品溶液;(2) reference substance solution preparation: get notoginseng saponin R1, tetrahydropalmatine and oleanolic acid reference substance dried under reduced pressure to constant weight and add methanol to make mixed reference substance solution;
    (3)测定:分别精密量取供试品溶液和对照品溶液,进行HPLC分析,采用梯度洗脱,流动相A相:乙腈,流动相B相:0.15%磷酸水溶液;对高效液相色谱测定所得图谱进行分析处理,即得颈痛颗粒指纹图谱;(3) Determination: Precisely measure the test solution and the reference solution respectively, carry out HPLC analysis, adopt gradient elution, mobile phase A phase: acetonitrile, mobile phase B phase: 0.15% phosphoric acid aqueous solution; The obtained spectrum is analyzed and processed to obtain the fingerprint spectrum of Ningtong Granules;
    所述步骤(1)和(2)之间并不存在先后顺序之分。There is no order of precedence between the steps (1) and (2).
  3. 如权利要求2所述的方法,其特征在于,所述步骤(1)中称取颈痛颗粒加入甲醇后超声10-30min(优选为20min),其中颈痛颗粒:甲醇的比为(450-550)mg:(8-12)mL(优选为500mg:10mL);超声提取后摇匀过滤,滤液过0.22μm微孔滤膜后得供试品溶液。The method of claim 2, wherein in the step (1), the Neck Pain Granules are weighed and added to methanol for 10-30 min (preferably 20 min), wherein the ratio of Neck Pain Granules: methanol is (450- 550) mg: (8-12) mL (preferably 500 mg: 10 mL); after ultrasonic extraction, shake well and filter, and pass the filtrate through a 0.22 μm microporous membrane to obtain the test solution.
  4. 如权利要求2所述的方法,其特征在于,所述步骤(2)中混合对照品溶液的配制方法如下:精密称取三七皂苷R1标准品0.0100g、延胡索乙素标准品0.0099g和齐墩果酸标准品0.0099g置10mL容量瓶中,加甲醇溶解并稀释至刻度,配置混合标准品溶液。The method according to claim 2, characterized in that, in the step (2), the compounding method of the mixed reference solution is as follows: accurately weigh 0.0100 g of notoginsenoside R1 standard product, 0.0099 g of tetrahydropalmatine standard product and q. Put 0.0099g of leanolic acid standard in a 10mL volumetric flask, add methanol to dissolve and dilute to the mark, and prepare a mixed standard solution.
  5. 如权利要求2所述的方法,其特征在于,所述步骤(3)中色谱柱为CAPCELL PAK C18 MGII,4.6mm×250mm,5μm;流动相流速为1ml/min;柱温为30℃;检测波长为300nm,进样量10μL。The method according to claim 2, characterized in that, in the step (3), the chromatographic column is CAPCELL PAK C18 MGII, 4.6 mm×250 mm, 5 μm; the flow rate of the mobile phase is 1 ml/min; the column temperature is 30°C; The wavelength was 300 nm, and the injection volume was 10 μL.
  6. 如权利要求2所述的方法,其特征在于,步骤(3)中梯度洗脱方式为:0~15min,2%A→15%A;15~30min,15%A→30%A;30~45min,30%A→50%A;45~60min,50%A→65%A;60~75min,65%A→100%A。The method according to claim 2, wherein the gradient elution mode in step (3) is: 0~15min, 2%A→15%A; 15~30min, 15%A→30%A; 30~30min 45min, 30%A→50%A; 45~60min, 50%A→65%A; 60~75min, 65%A→100%A.
  7. 权利要求1-6任一项所述方法获得的颈痛颗粒的指纹图谱。The fingerprint of the neck pain granules obtained by the method of any one of claims 1-6.
  8. 权利要求1-6任一项所述方法和/或权利要求7所述指纹图谱在颈痛颗粒质量控制中的应用。Application of the method according to any one of claims 1 to 6 and/or the fingerprint according to claim 7 in the quality control of Jingtong granules.
  9. 一种颈痛颗粒的质量控制方法,其特征在于,所述方法包括:取多批次颈痛颗粒按照权利要求1-6任一项所述方法得到颈痛颗粒指纹图谱,将多个批次颈痛颗粒指纹图谱按照均值法生成得到对照指纹图谱;A quality control method for Ningtong Granules, characterized in that, the method comprises: taking multiple batches of Ningtong Granules to obtain a fingerprint of Ningtong Granules according to the method according to any one of claims 1-6, The fingerprints of Jingtong Granules were generated according to the mean value method to obtain the control fingerprints;
    取待检测样品制备供试品溶液,按照权利要求1-6任一项所述方法得到颈痛颗粒指纹图谱;Get the sample to be detected to prepare the test solution, and obtain the fingerprint of Neck Pain Granules according to the method described in any one of claims 1-6;
    将待检测样品指纹图谱与颈痛颗粒对照指纹图谱进行相似性比较。The similarity between the fingerprints of the samples to be tested and the control fingerprints of Jingtong Granules was compared.
  10. 如权利要求9所述的质量控制方法,其特征在于,所述相似性比较包括采用夹角余弦法和/或相关系数法进行。The quality control method according to claim 9, wherein the similarity comparison comprises using an included angle cosine method and/or a correlation coefficient method.
PCT/CN2021/098703 2020-07-31 2021-06-07 Method for establishing fingerprint spectrum of cervicodynia treatment granules, and application thereof WO2022022065A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010760880.8A CN111999423B (en) 2020-07-31 2020-07-31 Establishment method and application of neck pain granule fingerprint spectrum
CN202010760880.8 2020-07-31

Publications (1)

Publication Number Publication Date
WO2022022065A1 true WO2022022065A1 (en) 2022-02-03

Family

ID=73462638

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/098703 WO2022022065A1 (en) 2020-07-31 2021-06-07 Method for establishing fingerprint spectrum of cervicodynia treatment granules, and application thereof

Country Status (2)

Country Link
CN (1) CN111999423B (en)
WO (1) WO2022022065A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114894917A (en) * 2022-04-06 2022-08-12 山东步长制药股份有限公司 Detection and fingerprint spectrum construction method for volatile components of nardostachys chinensis bunge
CN114965776A (en) * 2022-05-27 2022-08-30 重庆希尔安药业有限公司 Method for establishing feature spectrum of children Huanglong granules, standard feature spectrum and application thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111999423B (en) * 2020-07-31 2022-11-22 山东明仁福瑞达制药股份有限公司 Establishment method and application of neck pain granule fingerprint spectrum
CN112798721B (en) * 2021-01-29 2022-10-25 山东明仁福瑞达制药股份有限公司 Fingerprint construction method and application of traditional Chinese medicine preparation for treating cervical spondylosis

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060292246A1 (en) * 2005-06-20 2006-12-28 Rey-Yuh Wu Characteristic mass spectral fingerprint setting method and rapid identification method for Chinese herbal medicines and prescriptions
CN108226321A (en) * 2017-12-07 2018-06-29 扬子江药业集团江苏制药股份有限公司 The fingerprint atlas detection method and its finger-print of Bi bells stomachache particle
CN110824068A (en) * 2019-12-13 2020-02-21 淄博市食品药品检验研究院 Establishment method and application of Irdu cold particle fingerprint
CN110836944A (en) * 2019-12-13 2020-02-25 淄博市食品药品检验研究院 HPLC fingerprint spectrum establishment method for pediatric exterior syndrome relieving granules
CN111175428A (en) * 2020-01-07 2020-05-19 江苏省中医院 Method for detecting fingerprint of kidney-tonifying pregnancy-assisting granules
CN111999423A (en) * 2020-07-31 2020-11-27 山东明仁福瑞达制药股份有限公司 Establishment method and application of neck pain granule fingerprint spectrum

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104887771A (en) * 2014-03-06 2015-09-09 山东明仁福瑞达制药股份有限公司 Medicinal preparation for treating nerve-root cervical spondylopathy, and preparation method and quality detection method thereof
CN105929080B (en) * 2016-06-16 2019-02-22 山东明仁福瑞达制药股份有限公司 A kind of detection method of Chinese materia medica preparation that treating nerve root cervical vertebra sickness

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060292246A1 (en) * 2005-06-20 2006-12-28 Rey-Yuh Wu Characteristic mass spectral fingerprint setting method and rapid identification method for Chinese herbal medicines and prescriptions
CN108226321A (en) * 2017-12-07 2018-06-29 扬子江药业集团江苏制药股份有限公司 The fingerprint atlas detection method and its finger-print of Bi bells stomachache particle
CN110824068A (en) * 2019-12-13 2020-02-21 淄博市食品药品检验研究院 Establishment method and application of Irdu cold particle fingerprint
CN110836944A (en) * 2019-12-13 2020-02-25 淄博市食品药品检验研究院 HPLC fingerprint spectrum establishment method for pediatric exterior syndrome relieving granules
CN111175428A (en) * 2020-01-07 2020-05-19 江苏省中医院 Method for detecting fingerprint of kidney-tonifying pregnancy-assisting granules
CN111999423A (en) * 2020-07-31 2020-11-27 山东明仁福瑞达制药股份有限公司 Establishment method and application of neck pain granule fingerprint spectrum

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114894917A (en) * 2022-04-06 2022-08-12 山东步长制药股份有限公司 Detection and fingerprint spectrum construction method for volatile components of nardostachys chinensis bunge
CN114894917B (en) * 2022-04-06 2023-10-20 山东步长制药股份有限公司 Method for detecting volatile components of rhizoma nardostachyos and constructing fingerprint
CN114965776A (en) * 2022-05-27 2022-08-30 重庆希尔安药业有限公司 Method for establishing feature spectrum of children Huanglong granules, standard feature spectrum and application thereof
CN114965776B (en) * 2022-05-27 2024-04-16 重庆希尔安药业有限公司 Method for establishing characteristic spectrum of pediatric Huanglong granule and standard characteristic spectrum and application thereof

Also Published As

Publication number Publication date
CN111999423A (en) 2020-11-27
CN111999423B (en) 2022-11-22

Similar Documents

Publication Publication Date Title
WO2022022065A1 (en) Method for establishing fingerprint spectrum of cervicodynia treatment granules, and application thereof
CN105147800B (en) Detection method of ephedra, apricot, gypsum and licorice decoction formula granules
CN109633037B (en) UPLC fingerprint construction method and detection method of Angong Niuhuang Wan
CN114200046B (en) Construction method, detection method and application of fingerprint spectrum of Juanbi decoction composition
Peng-Peng et al. Metabolomics analysis and rapid identification of changes in chemical ingredients in crude and processed Astragali Radix by UPLC-QTOF-MS combined with novel informatics UNIFI platform
CN103399094A (en) Fingerprint spectrum detection method of pills for treating hyperplasia of mammary glands
CN101672834B (en) Method for detecting quality of Chinese medicinal preparation for treating diabetic retinopathy
CN112526014B (en) Jinyinliang oral liquid fingerprint spectrum and establishing method thereof
CN105572261A (en) Method for building fingerprint spectrum of Xianlinggubao capsules and quality detection method of Xianlinggubao capsules
CN105486762B (en) A kind of high-efficiency liquid-phase fingerprint detection method of female clever ball
CN103424498A (en) Establishing method and application of fingerprint of detoxifying and kidney harmonizing capsule
CN102049028B (en) Method for establishing HPLC (high performance liquid chromatography) fingerprint graphic for ointment for unblocking collaterals and relieving pain as well as standard fingerprint graphic thereof
CN114910576B (en) Method for detecting aconite monoester type alkaloid component in cassia twig, chinese herbaceous peony and rhizoma anemarrhenae soup
CN109115904B (en) Construction method and application of UPLC fingerprint of Dingkundan
CN108226325A (en) Roripa montana gives birth to the method for building up of arteries and veins oral liquid composition finger-print
CN112345679B (en) Fingerprint characteristic spectrum of Wuling preparation, establishing method and application thereof
CN110398551B (en) Establishment method of ginseng fruit medicinal material fingerprint spectrum and standard fingerprint spectrum thereof
CN114088823A (en) Method for measuring content of multi-index components in Tongtian oral liquid
CN102928538A (en) Radix salvia miltiorrhiza fingerprint establishment method and standard fingerprint
CN101936974B (en) Method for identifying Chinese patent drugs by using mixed contrast
CN101926863A (en) Method for identifying Nigella glandulifera Freyn medicinal material
CN105353065A (en) Establishing method of HPLC (high-performance liquid chromatography) fingerprint spectrum of lychee seeds, standard fingerprint spectrum obtained with method and application of standard fingerprint spectrum
CN110954636B (en) Detection method of dry paste fingerprint of radix stephaniae tetrandrae and radix astragali decoction
CN112798721B (en) Fingerprint construction method and application of traditional Chinese medicine preparation for treating cervical spondylosis
CN116678978B (en) Establishment of fingerprint spectrum and chemical component content determination method for chuanxiong tea powder

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21848905

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21848905

Country of ref document: EP

Kind code of ref document: A1